Xanthine derivatives
AssigneeKyowa Hakko Kogyo Co., Ltd.
InventorsFumio Suzuki, Junichi Shimada, Akio Ishii, Tetsuji Ohno, Akira Karasawa, Kazuhiro Kubo, Hiromi Nonaka
Life of this patent
Estimating the term…
Loading patent…
AssigneeKyowa Hakko Kogyo Co., Ltd.
InventorsFumio Suzuki, Junichi Shimada, Akio Ishii, Tetsuji Ohno, Akira Karasawa, Kazuhiro Kubo, Hiromi Nonaka
Estimating the term…
Novel xanthine compounds represented by the following formula: ##STR1## wherein each of X.sup.1 and X.sup.2 independently represents oxygen or sulfur; and Q represents; ##STR2## where ----- represents a single bond or a double bond; Y represents a single bond or alkylene, n represents 0 or 1, each of W.sup.1 and W.sup.2 independently represents hydrogen, lower alkyl or amino, Z represents --CH.sub.2 -, --O--, --S-- or --NH--; represents ##STR3## each of R.sup.1 and R.sup.2 independently represents hydrogen, lower alkyl, allyl or propargyl; and R.sup.3 represents hydrogen or lower alkyl, and when Q represents the groups other than ##STR4## each of R.sup.1, R.sup.2 and R.sup.3 independently represents hydrogen or lower alkyl; provided that when Q is ##STR5## then R.sup.1 R.sup.2 and R.sup.3 are not simultaneously methyl; and pharmaceutically acceptable salts thereof have a diuretic effect, a renal-protecting effect and a bronchodilatory effect.
Xanthine compounds represented by the following formula (I):
8-(Noradamantan-3-yl)-1,3-dipropylxanthine or a pharmaceutically acceptable salt thereof.
1,3-Diallyl-8-(3-noradamantyl)xanthine, or a pharmaceutically acceptable salt thereof.
3-Allyl-8-(3-noradamantyl)-1-propargylxanthine, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.